Verizon, a leading American wireless network operator, was previously a division of Verizon Communications. This telecommunications powerhouse provides a wide range of communication, technology, and entertainment services globally. Operating through its Verizon Consumer Group and Verizon Business Group segments, the company offers wireless services under brands like Verizon and TracFone, as well as fixed wireless access broadband and wireline services across various regions in the United States. Additionally, it delivers a variety of products such as smartphones, tablets, and smartwatches.
Chevron Corporation, an American energy multinational, specializes in oil and gas operations worldwide. It offers a stable investment opportunity in the energy sector with a generous dividend payout. Through its subsidiaries, Chevron engages in integrated energy and chemicals operations, including exploration, production, transportation, and marketing of crude oil and natural gas. The company also refines petroleum products, manufactures renewable fuels, and markets various petrochemical products.
Amgen Inc., a global biotech company, focuses on discovering, developing, and delivering human therapeutics. It is a favored choice among investors seeking exposure to the growing biotech industry. With a strong track record in developing innovative treatments, Amgen is considered a reliable investment option in the dynamic healthcare sector.
Amgen Inc. (NASDAQ: AMGN) is a global leader in the discovery, development, and delivery of human therapeutics, with a focus on areas such as Inflammation, Oncology/hematology, Bone health, Cardiovascular disease, Nephrology, and Neuroscience. Their products include Enbrel for plaque psoriasis and arthritis, Neulasta for reducing infection risk in cancer patients, Prolia for osteoporosis, Xgeva for skeletal-related events prevention, and more.
Johnson & Johnson (NYSE: JNJ) is a renowned American multinational corporation in the pharmaceutical, biotechnology, and medical technologies sectors. With a diverse product portfolio and strong brand reputation, JNJ is considered a conservative investment choice with a 3.46% dividend yield. The company’s Innovative Medicine segment provides products in various therapeutic areas like Immunology, Infectious diseases, Oncology, Cardiovascular health, Pulmonary hypertension, and more.
Merck & Co. Inc. (NYSE: MRK) is a global healthcare powerhouse known for its development of medicines, vaccines, biological therapies, and animal health products. With a solid 3.30% dividend yield, Merck operates in two segments: Pharmaceutical and Animal Health. The Pharmaceutical segment offers a wide range of products in Oncology, Immunology, Neurology, Cardiovascular health, and more. The Animal Health segment focuses on veterinary pharmaceuticals and vaccines.
Merck provides a range of innovative products and services aimed at enhancing digital connectivity, identification, traceability, and monitoring within various industries. The company caters to a diverse clientele, including:
– Drug wholesalers
– Retailers
– Hospitals
– Government agencies
– Managed healthcare providers (e.g., health maintenance organizations)
– Pharmacy benefit managers and other institutions
– Physicians
– Physician distributors
– Veterinarians
– Animal producers
Merck’s offerings extend across these sectors, providing essential solutions and support to ensure efficient operations and optimal outcomes.
